Prediction of individual survival and trial outcomes for anti-PDL1 treatment in non-small cell lung cancer using blood markers-based kinetics-machine learning

Data Availability

Qualified researchers may request access to individual patient level data through the clinical study data request platform (https://vivli.org/). Further details on Roche's criteria for eligible studies are available here (https://vivli.org/members/ourmembers/). For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents please refer to the Roche website (https://www.roche.com/innovation/process/clinical-trials/data-sharing/).

https://vivli.org/

https://www.roche.com/innovation/process/clinical-trials/data-sharing/